Exact Mass: 493.3226

Tiamulin

C28H47NO4S (493.3226)

D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic Same as: D06127 CONFIDENCE standard compound; INTERNAL_ID 1055

Zygadenin

C27H43NO7 (493.3039)

Syringolin A

C24H39N5O6 (493.29)

A syrbactin that has a (3E,9E)-2,7-dioxo-1,6-diazacyclododeca-3,9-diene skeleton that is substituted by an isopropyl group at position 5 and by a [(2S)-2-({[(1S)-1-carboxy-2-methylpropyl]carbamoyl}amino)-3-methylbutanoyl]nitrilo group at the 8-pro-S position. It is produced by the pathogenic bacterium Pseudomonas syringae pv. syringae.

LysoPC(16:1(9Z)/0:0)

C24H48NO7P (493.3168)

LysoPC(16:1(9Z)) is a lysophospholipid (LyP). It is a monoglycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. Lysophosphatidylcholines can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) position. Fatty acids containing 16, 18 and 20 carbons are the most common. LysoPC(16:1(9Z)), in particular, consists of one chain of palmitoleic acid at the C-1 position. The palmitoleic acid moiety is derived from animal fats and vegetable oils. Lysophosphatidylcholine is found in small amounts in most tissues. It is formed by hydrolysis of phosphatidylcholine by the enzyme phospholipase A2, as part of the de-acylation/re-acylation cycle that controls its overall molecular species composition. It can also be formed inadvertently during extraction of lipids from tissues if the phospholipase is activated by careless handling. In blood plasma significant amounts of lysophosphatidylcholine are formed by a specific enzyme system, lecithin:cholesterol acyltransferase (LCAT), which is secreted from the liver. The enzyme catalyzes the transfer of the fatty acids of position sn-2 of phosphatidylcholine to the free cholesterol in plasma, with formation of cholesterol esters and lysophosphatidylcholine. Lysophospholipids have a role in lipid signaling by acting on lysophospholipid receptors (LPL-R). LPL-Rs are members of the G protein-coupled receptor family of integral membrane proteins. [HMDB] LysoPC(16:1(9Z)/0:0) is a lysophospholipid (LyP). It is a monoglycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. Lysophosphatidylcholines can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) position. Fatty acids containing 16, 18 and 20 carbons are the most common. LysoPC(16:1(9Z)/0:0), in particular, consists of one chain of palmitoleic acid at the C-1 position. The palmitoleic acid moiety is derived from animal fats and vegetable oils. Lysophosphatidylcholine is found in small amounts in most tissues. It is formed by hydrolysis of phosphatidylcholine by the enzyme phospholipase A2, as part of the de-acylation/re-acylation cycle that controls its overall molecular species composition. It can also be formed inadvertently during extraction of lipids from tissues if the phospholipase is activated by careless handling. In blood plasma significant amounts of lysophosphatidylcholine are formed by a specific enzyme system, lecithin:cholesterol acyltransferase (LCAT), which is secreted from the liver. The enzyme catalyzes the transfer of the fatty acids of position sn-2 of phosphatidylcholine to the free cholesterol in plasma, with formation of cholesterol esters and lysophosphatidylcholine. Lysophospholipids have a role in lipid signaling by acting on lysophospholipid receptors (LPL-R). LPL-Rs are members of the G protein-coupled receptor family of integral membrane proteins.

Cytochalasin Npho

C30H39NO5 (493.2828)

Cytochalasin Npho is a mycotoxin from Phomopsis sp Mycotoxin from Phomopsis species

(5Z)-7-[(1R,2R,5S)-5-Hydroxy-2-[(1E,3S,5Z)-3-hydroxyocta-1,5-dien-1-yl]-3-oxocyclopentyl]hept-5-enoylcarnitine

C27H43NO7 (493.3039)

(5Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S,5Z)-3-hydroxyocta-1,5-dien-1-yl]-3-oxocyclopentyl]hept-5-enoylcarnitine is an acylcarnitine. More specifically, it is an (5Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S,5Z)-3-hydroxyocta-1,5-dien-1-yl]-3-oxocyclopentyl]hept-5-enoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (5Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S,5Z)-3-hydroxyocta-1,5-dien-1-yl]-3-oxocyclopentyl]hept-5-enoylcarnitine is therefore classified as a long chain AC. As a long-chain acylcarnitine (5Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S,5Z)-3-hydroxyocta-1,5-dien-1-yl]-3-oxocyclopentyl]hept-5-enoylcarnitine is generally formed through esterification with long-chain fatty acids obtained from the diet. The main function of most long-chain acylcarnitines is to ensure long chain fatty acid transport into the mitochondria (PMID: 22804748). Altered levels of long-chain acylcarnitines can serve as useful markers for inherited disorders of long-chain fatty acid metabolism. Carnitine palmitoyltransferase I (CPT I, EC:2.3.1.21) is involved in the synthesis of long-chain acylcarnitines (more than C12) on the mitochondrial outer membrane. Elevated serum/plasma levels of long-chain acylcarnitines are not only markers for incomplete FA oxidation but also are indicators of altered carbohydrate and lipid metabolism. High serum concentrations of long-chain acylcarnitines in the postprandial or fed state are markers of insulin resistance and arise from insulins inability to inhibit CPT-1-dependent fatty acid metabolism in muscles and the heart (PMID: 19073774). Increased intracellular content of long-chain acylcarnitines is thought to serve as a feedback inhibition mechanism of insulin action (PMID: 23258903). In healthy subjects, increased concentrations of insulin effectively inhibits long-chain acylcarnitine production. Several studies have also found increased levels of circulating long-chain acylcarnitines in chronic heart failure patients (PMID: 26796394). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

Chenodeoxycholylthreonine

C28H47NO6 (493.3403)

Chenodeoxycholylthreonine belongs to a class of molecules known as bile acid-amino acid conjugates. These are bile acid conjugates that consist of a primary bile acid such as cholic acid, doxycholic acid and chenodeoxycholic acid, conjugated to an amino acid. Chenodeoxycholylthreonine consists of the bile acid chenodeoxycholic acid conjugated to the amino acid Threonine conjugated at the C24 acyl site.Bile acids play an important role in regulating various physiological systems, such as fat digestion, cholesterol metabolism, vitamin absorption, liver function, and enterohepatic circulation through their combined signaling, detergent, and antimicrobial mechanisms (PMID: 34127070). Bile acids also act as detergents in the gut and support the absorption of fats through the intestinal membrane. These same properties allow for the disruption of bacterial membranes, thereby allowing them to serve a bacteriocidal or bacteriostatic function. In humans (and other mammals) bile acids are normally conjugated with the amino acids glycine and taurine by the liver. This conjugation catalyzed by two liver enzymes, bile acid CoA ligase (BAL) and bile acid CoA: amino acid N-acyltransferase (BAT). Glycine and taurine bound BAs are also referred to as bile salts due to their decreased pKa and complete ionization resulting in these compounds being present as anions in vivo. Unlike glycine and taurine-conjugated bile acids, these recently discovered bile acids, such as Chenodeoxycholylthreonine, are produced by the gut microbiota, making them secondary bile acids (PMID: 32103176) or microbially conjugated bile acids (MCBAs) (PMID: 34127070). Evidence suggests that these bile acid-amino acid conjugates are produced by microbes belonging to Clostridia species (PMID: 32103176). These unusual bile acid-amino acid conjugates are found in higher frequency in patients with inflammatory bowel disease (IBD), cystic fibrosis (CF) and in infants (PMID: 32103176). Chenodeoxycholylthreonine appears to act as an agonist for the farnesoid X receptor (FXR) and it can also lead to reduced expression of bile acid synthesis genes (PMID: 32103176). It currently appears that microbially conjugated bile acids (MCBAs) or amino acid-bile acid conjugates are only conjugated to cholic acid, deoxycholic acid and chenodeoxycholic acid (PMID: 34127070). It has been estimated that if microbial conjugation of bile acids is very promiscuous and occurs for all potential oxidized, epimerized, and dehydroxylated states of each hydroxyl group present on cholic acid (C3, C7, C12) in addition to ring orientation, the total number of potential human bile acid conjugates could be over 2800 (PMID: 34127070).

Deoxycholylthreonine

C28H47NO6 (493.3403)

Deoxycholylthreonine belongs to a class of molecules known as bile acid-amino acid conjugates. These are bile acid conjugates that consist of a primary bile acid such as cholic acid, doxycholic acid and chenodeoxycholic acid, conjugated to an amino acid. Deoxycholylthreonine consists of the bile acid deoxycholic acid conjugated to the amino acid Threonine conjugated at the C24 acyl site.Bile acids play an important role in regulating various physiological systems, such as fat digestion, cholesterol metabolism, vitamin absorption, liver function, and enterohepatic circulation through their combined signaling, detergent, and antimicrobial mechanisms (PMID: 34127070). Bile acids also act as detergents in the gut and support the absorption of fats through the intestinal membrane. These same properties allow for the disruption of bacterial membranes, thereby allowing them to serve a bacteriocidal or bacteriostatic function. In humans (and other mammals) bile acids are normally conjugated with the amino acids glycine and taurine by the liver. This conjugation catalyzed by two liver enzymes, bile acid CoA ligase (BAL) and bile acid CoA: amino acid N-acyltransferase (BAT). Glycine and taurine bound BAs are also referred to as bile salts due to their decreased pKa and complete ionization resulting in these compounds being present as anions in vivo. Unlike glycine and taurine-conjugated bile acids, these recently discovered bile acids, such as Deoxycholylthreonine, are produced by the gut microbiota, making them secondary bile acids (PMID: 32103176) or microbially conjugated bile acids (MCBAs) (PMID: 34127070). Evidence suggests that these bile acid-amino acid conjugates are produced by microbes belonging to Clostridia species (PMID: 32103176). These unusual bile acid-amino acid conjugates are found in higher frequency in patients with inflammatory bowel disease (IBD), cystic fibrosis (CF) and in infants (PMID: 32103176). Deoxycholylthreonine appears to act as an agonist for the farnesoid X receptor (FXR) and it can also lead to reduced expression of bile acid synthesis genes (PMID: 32103176). It currently appears that microbially conjugated bile acids (MCBAs) or amino acid-bile acid conjugates are only conjugated to cholic acid, deoxycholic acid and chenodeoxycholic acid (PMID: 34127070). It has been estimated that if microbial conjugation of bile acids is very promiscuous and occurs for all potential oxidized, epimerized, and dehydroxylated states of each hydroxyl group present on cholic acid (C3, C7, C12) in addition to ring orientation, the total number of potential human bile acid conjugates could be over 2800 (PMID: 34127070).

1-(9Z-Nonadecenoyl)-glycero-3-phosphoethanolamine

C24H48NO7P (493.3168)

(2R)-2-{[(9Z)-Hexadec-9-enoyl]oxy}-3-hydroxypropyl 2-(trimethylazaniumyl)ethyl phosphate

C24H48NO7P (493.3168)

N(4)-Oleylcytosine arabinoside

C27H47N3O5 (493.3516)

PC(16:1(9E)/0:0)

C24H48NO7P (493.3168)

[(2R,3S,4S,6R,7S,8R)-4-Ethenyl-3-hydroxy-2,4,7,14-tetramethyl-9-oxo-6-tricyclo[5.4.3.01,8]tetradecanyl] 2-[2-(diethylamino)ethylsulfanyl]acetate

C28H47NO4S (493.3226)

Glycolipids

C24H50N2O6P+ (493.3406)

Glycolipids is practically insoluble (in water) and a moderately acidic compound (based on its pKa). Glycolipids can be found in chayote, chinese mustard, swamp cabbage, and winter squash, which makes glycolipids a potential biomarker for the consumption of these food products. Glycolipids are lipids with a carbohydrate attached by a glycosidic bond. Their role is to maintain the stability of the cell membrane and to facilitate cellular recognition, which is crucial to the immune response and in the connections that allow cells to connect to one another to form tissues. Glycolipids are found on the surface of all eukaryotic cell membranes, where they extend from the phospholipid bilayer into the extracellular environment .

Holantosine E

C28H47NO6 (493.3403)

Vinylamycin

C26H43N3O6 (493.3152)

A 15-membered cyclodepsipeptide isolated from Streptomyces sp.M1982-63F1. It exhibits moderate activity against Gram-positive bacteria.

INDANOMYCIN

C31H43NO4 (493.3192)

An indene that is (3aS,7aR)-2,3,3a,4,5,7a-hexahydro-1H-indene which is substituted at the 2-pro-R position by a 1H-pyrrol-2-ylcarbonyl group, at the 9-pro-S position by an ethyl group, and at the 5-pro-R position by a hexa-1,3-dineyl group in which position 4 has been substituted by a (2R,3S,6R)-6-[(1R)-1-carboxyethyl]-3-methyltetrahydropyran-2-yl group. It exhibits activity against Gram-positive bacteria as well as antihypertensive and antitumour. It also functions as an effective growth promoter for ruminants.

Epoxycytochalasin H

C30H39NO5 (493.2828)

CYTOCHALASIN H

C30H39NO5 (493.2828)

cytochalasin U

C30H39NO5 (493.2828)

14-Acetylchasmanine

C27H43NO7 (493.3039)

Combimicin B1

C21H43N5O8 (493.3111)

Delbrusine

C27H43NO7 (493.3039)

Phosphatidylcholine lyso 16:1

C24H48NO7P (493.3168)

HexCer t18:0

C24H47NO9 (493.3251)

Annotation level-3

lyngbyatoxin A acetate

C30H43N3O3 (493.3304)

zoanthenol

C30H39NO5 (493.2828)

sarcotragin A

C31H43NO4 (493.3192)

chaetoconvosin B

C30H39NO5 (493.2828)

acoseptrigine

C27H43NO7 (493.3039)

laxiracemosin C

C32H47NO3 (493.3556)

28-Deoxyzoanthenamine

C30H39NO5 (493.2828)

PE(19:1(9Z)/0:0)

C24H48NO7P (493.3168)

arginyltyrosylarginine

C21H35N9O5 (493.2761)

LPC(1-acyl 16:1)-2

C24H48NO7P (493.3168)

MLS001332637-01!Tiamulin

C28H47NO4S (493.3226)

Sibiromycin-494 hemiaminal

C25H39N3O7 (493.2788)

Threonine conjugated chenodeoxycholic acid

C28H47NO6 (493.3403)

Ala Ile Lys Tyr

C24H39N5O6 (493.29)

Ala Ile Tyr Lys

C24H39N5O6 (493.29)

Ala Lys Ile Tyr

C24H39N5O6 (493.29)

Ala Lys Leu Tyr

C24H39N5O6 (493.29)

Ala Lys Tyr Ile

C24H39N5O6 (493.29)

Ala Lys Tyr Leu

C24H39N5O6 (493.29)

Ala Leu Lys Tyr

C24H39N5O6 (493.29)

Ala Leu Tyr Lys

C24H39N5O6 (493.29)

Ala Tyr Ile Lys

C24H39N5O6 (493.29)

Ala Tyr Lys Ile

C24H39N5O6 (493.29)

Ala Tyr Lys Leu

C24H39N5O6 (493.29)

Ala Tyr Leu Lys

C24H39N5O6 (493.29)

Phe Ile Lys Ser

C24H39N5O6 (493.29)

Phe Ile Ser Lys

C24H39N5O6 (493.29)

Phe Lys Ile Ser

C24H39N5O6 (493.29)

Phe Lys Leu Ser

C24H39N5O6 (493.29)

Phe Lys Ser Ile

C24H39N5O6 (493.29)

Phe Lys Ser Leu

C24H39N5O6 (493.29)

Phe Lys Thr Val

C24H39N5O6 (493.29)

Phe Lys Val Thr

C24H39N5O6 (493.29)

Phe Leu Lys Ser

C24H39N5O6 (493.29)

Phe Leu Ser Lys

C24H39N5O6 (493.29)

Phe Ser Ile Lys

C24H39N5O6 (493.29)

Phe Ser Lys Ile

C24H39N5O6 (493.29)

Phe Ser Lys Leu

C24H39N5O6 (493.29)

Phe Ser Leu Lys

C24H39N5O6 (493.29)

Phe Thr Lys Val

C24H39N5O6 (493.29)

Phe Thr Val Lys

C24H39N5O6 (493.29)

Phe Val Lys Thr

C24H39N5O6 (493.29)

Phe Val Thr Lys

C24H39N5O6 (493.29)

His Ile Lys Pro

C23H39N7O5 (493.3013)

His Ile Pro Lys

C23H39N7O5 (493.3013)

His Lys Ile Pro

C23H39N7O5 (493.3013)

His Lys Leu Pro

C23H39N7O5 (493.3013)

His Lys Pro Ile

C23H39N7O5 (493.3013)

His Lys Pro Leu

C23H39N7O5 (493.3013)

His Leu Lys Pro

C23H39N7O5 (493.3013)

His Leu Pro Lys

C23H39N7O5 (493.3013)

His Pro Ile Lys

C23H39N7O5 (493.3013)

His Pro Lys Ile

C23H39N7O5 (493.3013)

His Pro Lys Leu

C23H39N7O5 (493.3013)

His Pro Leu Lys

C23H39N7O5 (493.3013)

Arg Arg Tyr

C21H35N9O5 (493.2761)

Ile Ala Lys Tyr

C24H39N5O6 (493.29)

Ile Ala Tyr Lys

C24H39N5O6 (493.29)

Ile Phe Lys Ser

C24H39N5O6 (493.29)

Ile Phe Ser Lys

C24H39N5O6 (493.29)

Ile His Lys Pro

C23H39N7O5 (493.3013)

Ile His Pro Lys

C23H39N7O5 (493.3013)

Ile Lys Ala Tyr

C24H39N5O6 (493.29)

Ile Lys Phe Ser

C24H39N5O6 (493.29)

Ile Lys His Pro

C23H39N7O5 (493.3013)

Ile Lys Pro His

C23H39N7O5 (493.3013)

Ile Lys Ser Phe

C24H39N5O6 (493.29)

Ile Lys Tyr Ala

C24H39N5O6 (493.29)

Ile Pro His Lys

C23H39N7O5 (493.3013)

Ile Pro Lys His

C23H39N7O5 (493.3013)

Ile Ser Phe Lys

C24H39N5O6 (493.29)

Ile Ser Lys Phe

C24H39N5O6 (493.29)

Ile Tyr Ala Lys

C24H39N5O6 (493.29)

Ile Tyr Lys Ala

C24H39N5O6 (493.29)

Lys Ala Ile Tyr

C24H39N5O6 (493.29)

Lys Ala Leu Tyr

C24H39N5O6 (493.29)

Lys Ala Tyr Ile

C24H39N5O6 (493.29)

Lys Ala Tyr Leu

C24H39N5O6 (493.29)

Lys Phe Ile Ser

C24H39N5O6 (493.29)

Lys Phe Leu Ser

C24H39N5O6 (493.29)

Lys Phe Ser Ile

C24H39N5O6 (493.29)

Lys Phe Ser Leu

C24H39N5O6 (493.29)

Lys Phe Thr Val

C24H39N5O6 (493.29)

Lys Phe Val Thr

C24H39N5O6 (493.29)

Tyr Arg Arg

C21H35N9O5 (493.2761)

Lys His Ile Pro

C23H39N7O5 (493.3013)

Lys His Leu Pro

C23H39N7O5 (493.3013)

Lys His Pro Ile

C23H39N7O5 (493.3013)

Lys His Pro Leu

C23H39N7O5 (493.3013)

Lys Ile Ala Tyr

C24H39N5O6 (493.29)

Lys Ile Phe Ser

C24H39N5O6 (493.29)

Lys Ile His Pro

C23H39N7O5 (493.3013)

Lys Ile Pro His

C23H39N7O5 (493.3013)

Lys Ile Ser Phe

C24H39N5O6 (493.29)

Lys Ile Tyr Ala

C24H39N5O6 (493.29)

Lys Leu Ala Tyr

C24H39N5O6 (493.29)

Lys Leu Phe Ser

C24H39N5O6 (493.29)

Lys Leu His Pro

C23H39N7O5 (493.3013)

Lys Leu Pro His

C23H39N7O5 (493.3013)

Lys Leu Ser Phe

C24H39N5O6 (493.29)

Lys Leu Tyr Ala

C24H39N5O6 (493.29)

Lys Pro His Ile

C23H39N7O5 (493.3013)

Lys Pro His Leu

C23H39N7O5 (493.3013)

Lys Pro Ile His

C23H39N7O5 (493.3013)

Lys Pro Leu His

C23H39N7O5 (493.3013)

Lys Ser Phe Ile

C24H39N5O6 (493.29)

Lys Ser Phe Leu

C24H39N5O6 (493.29)

Lys Ser Ile Phe

C24H39N5O6 (493.29)

Lys Ser Leu Phe

C24H39N5O6 (493.29)

Lys Thr Phe Val

C24H39N5O6 (493.29)

Lys Thr Val Phe

C24H39N5O6 (493.29)

Lys Val Phe Thr

C24H39N5O6 (493.29)

Lys Val Thr Phe

C24H39N5O6 (493.29)

Lys Tyr Ala Ile

C24H39N5O6 (493.29)

Lys Tyr Ala Leu

C24H39N5O6 (493.29)

Lys Tyr Ile Ala

C24H39N5O6 (493.29)

Lys Tyr Leu Ala

C24H39N5O6 (493.29)

Leu Ala Lys Tyr

C24H39N5O6 (493.29)

Leu Ala Tyr Lys

C24H39N5O6 (493.29)

Leu Phe Lys Ser

C24H39N5O6 (493.29)

Leu Phe Ser Lys

C24H39N5O6 (493.29)

Leu His Lys Pro

C23H39N7O5 (493.3013)

Leu His Pro Lys

C23H39N7O5 (493.3013)

Leu Lys Ala Tyr

C24H39N5O6 (493.29)

Leu Lys Phe Ser

C24H39N5O6 (493.29)

Leu Lys His Pro

C23H39N7O5 (493.3013)

Leu Lys Pro His

C23H39N7O5 (493.3013)

Leu Lys Ser Phe

C24H39N5O6 (493.29)

Leu Lys Tyr Ala

C24H39N5O6 (493.29)

Leu Pro His Lys

C23H39N7O5 (493.3013)

Leu Pro Lys His

C23H39N7O5 (493.3013)

Leu Ser Phe Lys

C24H39N5O6 (493.29)

Leu Ser Lys Phe

C24H39N5O6 (493.29)

Leu Tyr Ala Lys

C24H39N5O6 (493.29)

Leu Tyr Lys Ala

C24H39N5O6 (493.29)

Arg Tyr Arg

C21H35N9O5 (493.2761)

Pro His Ile Lys

C23H39N7O5 (493.3013)

Pro His Lys Ile

C23H39N7O5 (493.3013)

Pro His Lys Leu

C23H39N7O5 (493.3013)

Pro His Leu Lys

C23H39N7O5 (493.3013)

Pro Ile His Lys

C23H39N7O5 (493.3013)

Pro Ile Lys His

C23H39N7O5 (493.3013)

Pro Lys His Ile

C23H39N7O5 (493.3013)

Pro Lys His Leu

C23H39N7O5 (493.3013)

Pro Lys Ile His

C23H39N7O5 (493.3013)

Pro Lys Leu His

C23H39N7O5 (493.3013)

Pro Leu His Lys

C23H39N7O5 (493.3013)

Pro Leu Lys His

C23H39N7O5 (493.3013)

Ser Phe Ile Lys

C24H39N5O6 (493.29)

Ser Phe Lys Ile

C24H39N5O6 (493.29)

Ser Phe Lys Leu

C24H39N5O6 (493.29)

Ser Phe Leu Lys

C24H39N5O6 (493.29)

Ser Ile Phe Lys

C24H39N5O6 (493.29)

Ser Ile Lys Phe

C24H39N5O6 (493.29)

Ser Lys Phe Ile

C24H39N5O6 (493.29)

Ser Lys Phe Leu

C24H39N5O6 (493.29)

Ser Lys Ile Phe

C24H39N5O6 (493.29)

Ser Lys Leu Phe

C24H39N5O6 (493.29)

Ser Leu Phe Lys

C24H39N5O6 (493.29)

Ser Leu Lys Phe

C24H39N5O6 (493.29)

Thr Phe Lys Val

C24H39N5O6 (493.29)

Thr Phe Val Lys

C24H39N5O6 (493.29)

Thr Lys Phe Val

C24H39N5O6 (493.29)

Thr Lys Val Phe

C24H39N5O6 (493.29)

Thr Val Phe Lys

C24H39N5O6 (493.29)

Thr Val Lys Phe

C24H39N5O6 (493.29)

Val Phe Lys Thr

C24H39N5O6 (493.29)

Val Phe Thr Lys

C24H39N5O6 (493.29)

Val Lys Phe Thr

C24H39N5O6 (493.29)

Val Lys Thr Phe

C24H39N5O6 (493.29)

Val Thr Phe Lys

C24H39N5O6 (493.29)

Val Thr Lys Phe

C24H39N5O6 (493.29)

Tyr Ala Ile Lys

C24H39N5O6 (493.29)

Tyr Ala Lys Ile

C24H39N5O6 (493.29)

Tyr Ala Lys Leu

C24H39N5O6 (493.29)

Tyr Ala Leu Lys

C24H39N5O6 (493.29)

Tyr Ile Ala Lys

C24H39N5O6 (493.29)

Tyr Ile Lys Ala

C24H39N5O6 (493.29)

Tyr Lys Ala Ile

C24H39N5O6 (493.29)

Tyr Lys Ala Leu

C24H39N5O6 (493.29)

Tyr Lys Ile Ala

C24H39N5O6 (493.29)

Tyr Lys Leu Ala

C24H39N5O6 (493.29)

Tyr Leu Ala Lys

C24H39N5O6 (493.29)

Tyr Leu Lys Ala

C24H39N5O6 (493.29)

PC(16:1/0:0)

C24H48NO7P (493.3168)

PC(16:1/0:0)[U]

C24H48NO7P (493.3168)

PC(P-17:0/0:0)

C25H52NO6P (493.3532)

LysoPC(16:1/0:0)

C24H48NO7P (493.3168)

PE(P-20:0/0:0)

C25H52NO6P (493.3532)

Cytochalasin Npho

C30H39NO5 (493.2828)

Intercedenside D_qt

C24H48NO7P (493.3168)

LPC O-17:1

C25H52NO6P (493.3532)

LPE 19:1

C24H48NO7P (493.3168)

LPE O-20:1

C25H52NO6P (493.3532)

PQ-10

C28H39N5O3 (493.3053)

praseodymium tris(hexamethyldisilazide)

C19H55N3Si6 (493.3011)

Borrelidin B

C28H47NO6 (493.3403)

1-[(9E)-hexadecenoyl]-sn-glycero-3-phosphocholine

C24H48NO7P (493.3168)

A lysophosphatidylcholine 16:1 in which the 1-acyl group is (9E)-hexadecenoyl.

Deoxycholylthreonine

C28H47NO6 (493.3403)

Chenodeoxycholylthreonine

C28H47NO6 (493.3403)

[2-[(E)-hexadec-9-enoyl]oxy-3-hydroxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C24H48NO7P (493.3168)

(5Z)-7-[(1R,2R,5S)-5-Hydroxy-2-[(1E,3S,5Z)-3-hydroxyocta-1,5-dien-1-yl]-3-oxocyclopentyl]hept-5-enoylcarnitine

C27H43NO7 (493.3039)

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (E)-nonadec-9-enoate

C24H48NO7P (493.3168)

1-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-[[(E)-octadec-9-enyl]amino]pyrimidin-2-one

C27H47N3O5 (493.3516)

[3-[(E)-hexadec-9-enoyl]oxy-2-hydroxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C24H48NO7P (493.3168)

CID 443604

C28H47NO4S (493.3226)

N-hexanoylphytosphingosine 1-phosphate(2-)

C24H48NO7P-2 (493.3168)

(2R)-2-{[(9Z)-Hexadec-9-enoyl]oxy}-3-hydroxypropyl 2-(trimethylazaniumyl)ethyl phosphate

C24H48NO7P (493.3168)

CerP(d15:0/10:0)

C25H52NO6P (493.3532)

(2R)-N-[[(10S,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N,1-dimethylpyrrolidine-2-carboxamide

C29H39N3O4 (493.294)

(2R)-N-[[(10S,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N,1-dimethylpyrrolidine-2-carboxamide

C29H39N3O4 (493.294)

(2R)-N-[[(10R,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N,1-dimethylpyrrolidine-2-carboxamide

C29H39N3O4 (493.294)

(2S)-N-[[(10S,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N,1-dimethylpyrrolidine-2-carboxamide

C29H39N3O4 (493.294)

(2R)-N-[[(10R,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N,1-dimethylpyrrolidine-2-carboxamide

C29H39N3O4 (493.294)

(2S)-N-[[(10R,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N,1-dimethylpyrrolidine-2-carboxamide

C29H39N3O4 (493.294)

(2S)-N-[[(10R,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N,1-dimethylpyrrolidine-2-carboxamide

C29H39N3O4 (493.294)

N-[(2S,3R)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-phenylacetamide

C29H39N3O4 (493.294)

(2R,3S)-2-[[cyclopentylmethyl(methyl)amino]methyl]-8-[2-(3-fluorophenyl)ethynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C29H36FN3O3 (493.2741)

N-[(4S,7R,8R)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-phenylacetamide

C29H39N3O4 (493.294)

N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(2-phenylethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide

C29H39N3O4 (493.294)

N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(2-phenylethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide

C29H39N3O4 (493.294)

N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(2-phenylethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide

C29H39N3O4 (493.294)

(2S)-N-[[(10S,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N,1-dimethylpyrrolidine-2-carboxamide

C29H39N3O4 (493.294)

(2R)-N-[[(10S,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N,1-dimethylpyrrolidine-2-carboxamide

C29H39N3O4 (493.294)

N-[(2R,3S)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-phenylacetamide

C29H39N3O4 (493.294)

N-[(2R,3R)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-phenylacetamide

C29H39N3O4 (493.294)

N-[(2R,3R)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-phenylacetamide

C29H39N3O4 (493.294)

N-[(4R,7R,8S)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-phenylacetamide

C29H39N3O4 (493.294)

N-[(4R,7S,8R)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-phenylacetamide

C29H39N3O4 (493.294)

N-[(4S,7R,8S)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-phenylacetamide

C29H39N3O4 (493.294)

N-[(4R,7R,8R)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-phenylacetamide

C29H39N3O4 (493.294)

N-[(4S,7S,8R)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-phenylacetamide

C29H39N3O4 (493.294)

N-[(4S,7S,8S)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-phenylacetamide

C29H39N3O4 (493.294)

N-[(4R,7S,8S)-5-(cyclopropylmethyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-phenylacetamide

C29H39N3O4 (493.294)

N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(2-phenylethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide

C29H39N3O4 (493.294)

N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(2-phenylethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide

C29H39N3O4 (493.294)

N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(2-phenylethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide

C29H39N3O4 (493.294)

N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(2-phenylethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide

C29H39N3O4 (493.294)

(2S)-N-[[(10S,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N,1-dimethylpyrrolidine-2-carboxamide

C29H39N3O4 (493.294)

(2R)-N-[[(10R,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N,1-dimethylpyrrolidine-2-carboxamide

C29H39N3O4 (493.294)

(2S)-N-[[(10R,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N,1-dimethylpyrrolidine-2-carboxamide

C29H39N3O4 (493.294)

(2R)-N-[[(10R,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N,1-dimethylpyrrolidine-2-carboxamide

C29H39N3O4 (493.294)

Arg-Tyr-Arg

C21H35N9O5 (493.2761)

Arg-Arg-Tyr

C21H35N9O5 (493.2761)

Tyr-Arg-Arg

C21H35N9O5 (493.2761)

N-[(2S,3S,4R)-3,4-dihydroxy-15-methyl-1-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexadecan-2-yl]formamide

C24H47NO9 (493.3251)

Ldgts 18:4

C28H47NO6 (493.3403)

[3-[(Z)-heptadec-9-enoxy]-2-hydroxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C25H52NO6P (493.3532)

2-aminoethyl [2-hydroxy-3-[(Z)-icos-11-enoxy]propyl] hydrogen phosphate

C25H52NO6P (493.3532)

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (Z)-nonadec-9-enoate

C24H48NO7P (493.3168)

Lnape 5:0/N-13:1

C23H44NO8P (493.2804)

Lnape 15:1/N-3:0

C23H44NO8P (493.2804)

Lnape 16:1/N-2:0

C23H44NO8P (493.2804)

Lnape 4:0/N-14:1

C23H44NO8P (493.2804)

Lnape 2:0/N-16:1

C23H44NO8P (493.2804)

Lnape 3:0/N-15:1

C23H44NO8P (493.2804)

Lnape 13:1/N-5:0

C23H44NO8P (493.2804)

Lnape 14:1/N-4:0

C23H44NO8P (493.2804)

[2-propanoyloxy-3-[(Z)-tridec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C24H48NO7P (493.3168)

3-Hydroxy-2-(2-hydroxytetradecanoylamino)undecane-1-sulfonic acid

C25H51NO6S (493.3437)

3-Hydroxy-2-(2-hydroxypentadecanoylamino)decane-1-sulfonic acid

C25H51NO6S (493.3437)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-heptadec-9-enoxy]propan-2-yl] acetate

C24H48NO7P (493.3168)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-pentadec-9-enoxy]propan-2-yl] butanoate

C24H48NO7P (493.3168)

3-Hydroxy-2-(2-hydroxytridecanoylamino)dodecane-1-sulfonic acid

C25H51NO6S (493.3437)

3-Hydroxy-2-(2-hydroxydodecanoylamino)tridecane-1-sulfonic acid

C25H51NO6S (493.3437)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tridec-9-enoxy]propan-2-yl] hexanoate

C24H48NO7P (493.3168)

[3-[(Z)-hexadec-9-enoyl]oxy-2-hydroxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C24H48NO7P (493.3168)

2-[hydroxy-[(E)-3-hydroxy-2-(octanoylamino)undec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C24H50N2O6P+ (493.3406)

[2-acetyloxy-3-[(Z)-tetradec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C24H48NO7P (493.3168)

[3-acetyloxy-2-[(Z)-tridec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C23H44NO8P (493.2804)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-hexadec-9-enoxy]propan-2-yl] propanoate

C24H48NO7P (493.3168)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tetradec-9-enoxy]propan-2-yl] pentanoate

C24H48NO7P (493.3168)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-butanoyloxypropan-2-yl] (Z)-tetradec-9-enoate

C23H44NO8P (493.2804)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-propanoyloxypropan-2-yl] (Z)-pentadec-9-enoate

C23H44NO8P (493.2804)

[1-acetyloxy-3-[2-aminoethoxy(hydroxy)phosphoryl]oxypropan-2-yl] (Z)-hexadec-9-enoate

C23H44NO8P (493.2804)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-pentanoyloxypropan-2-yl] (Z)-tridec-9-enoate

C23H44NO8P (493.2804)

lysoDGTS 18:4

C28H47NO6 (493.3403)

2-aminoethyl [(2R)-2-hydroxy-3-[(E)-icos-1-enoxy]propyl] hydrogen phosphate

C25H52NO6P (493.3532)

[(2R)-3-[(E)-hexadec-7-enoyl]oxy-2-hydroxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C24H48NO7P (493.3168)

2-[hydroxy-[(E)-3-hydroxy-2-(propanoylamino)hexadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C24H50N2O6P+ (493.3406)

2-[[(E)-2-acetamido-3-hydroxyheptadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C24H50N2O6P+ (493.3406)

2-[hydroxy-[(E)-3-hydroxy-2-(pentanoylamino)tetradec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C24H50N2O6P+ (493.3406)

2-[[(E)-2-(butanoylamino)-3-hydroxypentadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C24H50N2O6P+ (493.3406)

2-[hydroxy-[(E)-3-hydroxy-2-(undecanoylamino)oct-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C24H50N2O6P+ (493.3406)

2-[[(E)-2-(heptanoylamino)-3-hydroxydodec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C24H50N2O6P+ (493.3406)

2-[[(E)-2-(decanoylamino)-3-hydroxynon-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C24H50N2O6P+ (493.3406)

2-[[(E)-2-(hexanoylamino)-3-hydroxytridec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C24H50N2O6P+ (493.3406)

2-[hydroxy-[(E)-3-hydroxy-2-(nonanoylamino)dec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium

C24H50N2O6P+ (493.3406)

Zygadenine

C27H43NO7 (493.3039)

1-[(9Z)-hexadecenoyl]-sn-glycero-3-phosphocholine

C24H48NO7P (493.3168)

A 1-O-acyl-sn-glycero-3-phosphocholine in which the 1-acyl group is (9Z)-hexadecenoyl (palmitoleoyl).

1-(9Z-nonadecenoyl)-glycero-3-phosphoethanolamine

C24H48NO7P (493.3168)

2-(3-(1-(((4E,10E)-2,9-Dioxo-12-isopropyl-1,8-diazacyclododecane-4,10-diene-3-yl)carbamoyl)-2-methylpropyl)ureido)-3-methylbutyric acid

C24H39N5O6 (493.29)

2-[(9Z)-hexadecenoyl]-sn-glycero-3-phosphocholine

C24H48NO7P (493.3168)

A lysophosphatidylcholine(0:0/16:1) in which the 2-acyl group is specified as (9Z)-hexadecenoyl.

1-(1Z-heptadecenyl)-sn-glycero-3-phosphocholine

C25H52NO6P (493.3532)

1-(1Z-eicosenyl)-glycero-3-phosphoethanolamine

C25H52NO6P (493.3532)

[(9Z)-hexadecenoyl]-sn-glycero-3-phosphocholine

C24H48NO7P (493.3168)

A lysophosphatidylcholine 16:1 in which the acyl group is specified as (9Z)-hexadecenoyl and is located at either position 1 or 2.

lysophosphatidylcholine 16:1

C24H48NO7P (493.3168)

An lysophosphatidylcholine in which the acyl group is hexadecenoyl (position of double bond not specified). If R1 is hexadecenoyl and R2 is a hydrogen then the molecule is a 1-acyl-sn-glycero-3-phosphocholine. If R1 is a hydrogen and R2 is hexadecenoyl then the molecule is a 2-acyl-sn-glycero-3-phosphocholine.

lysophosphatidylcholine(0:0/16:1)

C24H48NO7P (493.3168)

A 2-acyl-sn-glycero-3-phosphocholine in which the 2-acyl group contains 16 carbons and 1 double bond.

Lysophosphatidylcholine(16:1/0:0)

C24H48NO7P (493.3168)

A 1-acyl-sn-glycero-3-phosphocholine in which the 1-acyl group contains 16 carbons and 1 double bond.

phosphatidylethanolamine 18:1 zwitterion

C23H44NO8P (493.2804)

A 1,2-diacyl-sn-glycero-3-phosphoethanolamine zwitterion in which the two acyl groups contain a total of 18 carbons and 1 double bond.

phosphatidylcholine 15:1

C23H44NO8P (493.2804)

A 1,2-diacyl-sn-glycero-3-phosphocholine in which the two acyl groups contain a total of 15 carbons and 1 double bond.

lysophosphatidylcholine (16:1/0:0)

C24H48NO7P (493.3168)

A lysophosphatidylcholine 16:1 in which the acyl group is located at position 1.

PC(15:1)

C23H44NO8P (493.2804)

Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

LdMePE(18:1)

C25H52NO6P (493.3532)

Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

LdMePE(17:1)

C24H48NO7P (493.3168)

Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

PC(16:1)

C24H48NO7P (493.3168)

Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

NA-Tyr 22:5(7Z,10Z,13Z,16Z,19Z)

C31H43NO4 (493.3192)

CAR DC21:3

C28H47NO6 (493.3403)

MGTS 18:4

C28H47NO6 (493.3403)

LPC 0:0/16:1

C24H48NO7P (493.3168)

LPC 16:1/0:0

C24H48NO7P (493.3168)

LPC 16:1(9Z)

C24H48NO7P (493.3168)

PC O-14:1/2:0

C24H48NO7P (493.3168)

PC O-16:1

C24H48NO7P (493.3168)

PC O-16:1(11Z)/0:0

C24H48NO7P (493.3168)

PC P-14:0/2:0

C24H48NO7P (493.3168)

PC P-14:0/2:0 or PC O-14:1/2:0

C24H48NO7P (493.3168)

PC P-16:0

C24H48NO7P (493.3168)

PC P-16:0 or PC O-16:1

C24H48NO7P (493.3168)

PC 11:0/4:1

C23H44NO8P (493.2804)

PC 15:1

C23H44NO8P (493.2804)

PC 15:1(9Z)/0:0

C23H44NO8P (493.2804)

LPE P-20:0

C25H52NO6P (493.3532)

LPE P-20:0 or LPE O-20:1

C25H52NO6P (493.3532)

PE O-13:1/6:0

C24H48NO7P (493.3168)

LPE 18:2;O

C23H44NO8P (493.2804)

PE 14:0/4:1

C23H44NO8P (493.2804)

PE 14:1/4:0

C23H44NO8P (493.2804)

PE 16:1/2:0

C23H44NO8P (493.2804)

PE 18:1

C23H44NO8P (493.2804)

CerP 14:0;O2/11:0

C25H52NO6P (493.3532)

CerP 14:1;O2/10:0;O

C24H48NO7P (493.3168)

CerP 15:0;O2/10:0

C25H52NO6P (493.3532)

CerP 24:1;O2;O

C24H48NO7P (493.3168)

CerP 25:0;O2

C25H52NO6P (493.3532)

GABA-AMCA

C28H47NO6 (493.3403)

GABA-BMCA

C28H47NO6 (493.3403)

GABA-CA

C28H47NO6 (493.3403)

GABA-HCA

C28H47NO6 (493.3403)

Thr-CDCA

C28H47NO6 (493.3403)

Thr-DCA

C28H47NO6 (493.3403)

Thr-HDCA

C28H47NO6 (493.3403)

Thr-UDCA

C28H47NO6 (493.3403)

ST 25:2;O5;Gly

C27H43NO7 (493.3039)

ST 26:1;O4;Gly

C28H47NO6 (493.3403)

ST 28:7;O3;Gly

C30H39NO5 (493.2828)

ST 29:6;O2;Gly

C31H43NO4 (493.3192)

ST 19:1;O2;HexNAc

C27H43NO7 (493.3039)

ST 20:0;O;HexNAc

C28H47NO6 (493.3403)

ST 25:3;O2;Tau

C27H43NO5S (493.2862)

5,8,13-trihydroxy-14-(1-hydroxy-4-methyldecan-3-yl)-3-isopropyl-6-methyl-11-methylidene-1-oxa-4,7,12-triazacyclotetradeca-4,7,9,12-tetraen-2-one

C26H43N3O6 (493.3152)

(2r)-2-[(5s,6r)-6-[(3e,5e)-6-[(1s,4s,5r)-1-ethyl-4-(1h-pyrrole-2-carbonyl)-2,3,3a,4,5,7a-hexahydro-1h-inden-5-yl]hexa-3,5-dien-3-yl]-5-methyloxan-2-yl]propanoic acid

C31H43NO4 (493.3192)

(1r,2s,3s,4s,5s,6r,8r,12r,13r,16r,19s,20s,21r)-14-ethyl-4,6,19,21-tetramethoxy-16-(methoxymethyl)-9,11-dioxa-14-azaheptacyclo[10.7.2.1²,⁵.0¹,¹³.0³,⁸.0⁸,¹².0¹⁶,²⁰]docosane

C27H43NO7 (493.3039)

3-benzyl-1,6,12-trihydroxy-4,10,12-trimethyl-5-methylidene-3h,3ah,4h,6h,6ah,9h,10h,11h,15h-cycloundeca[d]isoindol-15-yl acetate

C30H39NO5 (493.2828)

(3s,3ar,6s,6ar,10s,12r,15r,15ar)-3-benzyl-1,6,12-trihydroxy-4,5,10,12-tetramethyl-3h,3ah,6h,6ah,9h,10h,11h,15h-cycloundeca[d]isoindol-15-yl acetate

C30H39NO5 (493.2828)

(2-{[(2r)-3-[(9z)-hexadec-9-enoyloxy]-2-hydroxypropyl phosphonato]oxy}ethyl)trimethylazanium

C24H48NO7P (493.3168)

(1r,2s,3s,4s,5s,6r,8r,9s,10s,13r,16s,17s,18s)-11-ethyl-8-hydroxy-6,16,18-trimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl acetate

C27H43NO7 (493.3039)

(3r,6s,9e)-5,8,13-trihydroxy-14-(2-hydroxyethyl)-3-isopropyl-6-methyl-11-methylidene-15-(octan-2-yl)-1-oxa-4,7,12-triazacyclopentadeca-4,7,9,12-tetraen-2-one

C26H43N3O6 (493.3152)

(2e,4r,6r)-n-[(1's,3'r,4s,5s,5's,7'r)-6'-hydroxy-5-methoxy-6'-(2-oxopropyl)-4',8'-dioxaspiro[oxolane-2,2'-tricyclo[5.1.0.0³,⁵]octan]-4-yl]-4,6-dimethyldodec-2-enimidic acid

C27H43NO7 (493.3039)

2-{[(1-{[(3z,9z)-2,7-dihydroxy-5-isopropyl-1,6-diazacyclododeca-1,3,6,9-tetraen-8-yl]-c-hydroxycarbonimidoyl}-2-methylpropyl)-c-hydroxycarbonimidoyl]amino}-3-methylbutanoic acid

C24H39N5O6 (493.29)

3-benzyl-1,12-dihydroxy-5-(hydroxymethyl)-4,10,12-trimethyl-3h,3ah,4h,6ah,9h,10h,11h,15h-cycloundeca[d]isoindol-15-yl acetate

C30H39NO5 (493.2828)

4,8,12,15,22-pentamethyl-24-oxa-18-azaspiro[hexacyclo[18.3.1.0¹,¹⁸.0⁴,¹⁷.0⁶,¹⁵.0⁹,¹⁴]tetracosane-5,3'-oxolane]-11,16-diene-5',7,10-trione

C30H39NO5 (493.2828)

[4-(3,7-dimethylocta-1,6-dien-3-yl)-12-hydroxy-11-isopropyl-10-methyl-4,10,13-triazatricyclo[7.6.1.0⁵,¹⁶]hexadeca-1,5(16),6,8,12-pentaen-14-yl]methyl acetate

C30H43N3O3 (493.3304)

(2s)-2-({[(1s)-1-{[(3e,5s,8s,9e)-2,7-dihydroxy-5-isopropyl-1,6-diazacyclododeca-1,3,6,9-tetraen-8-yl]-c-hydroxycarbonimidoyl}-2-methylpropyl]-c-hydroxycarbonimidoyl}amino)-3-methylbutanoic acid

C24H39N5O6 (493.29)

2-{[(1-{[(3e,9e)-2,7-dihydroxy-5-isopropyl-1,6-diazacyclododeca-1,3,6,9-tetraen-8-yl]-c-hydroxycarbonimidoyl}-2-methylpropyl)-c-hydroxycarbonimidoyl]amino}-3-methylbutanoic acid

C24H39N5O6 (493.29)

(1s,2s,5s,6r,9r,12s,13r,16s,18s)-16-{[(2r,4s,5r,6r)-5-amino-4-methoxy-6-methyloxan-2-yl]oxy}-6,13-dimethyl-7-oxapentacyclo[10.8.0.0²,⁹.0⁵,⁹.0¹³,¹⁸]icosane-2,6-diol

C28H47NO6 (493.3403)

(1s,2s,6s,9s,10s,11r,12r,13s,14s,15s,18s,19s,22s,23r,25r)-6,10,19-trimethyl-24-oxa-4-azaheptacyclo[12.12.0.0²,¹¹.0⁴,⁹.0¹⁵,²⁵.0¹⁸,²³.0¹⁹,²⁵]hexacosane-10,12,13,14,22,23-hexol

C27H43NO7 (493.3039)

[(11s,14s)-4-[(3r)-3,7-dimethylocta-1,6-dien-3-yl]-12-hydroxy-11-isopropyl-10-methyl-4,10,13-triazatricyclo[7.6.1.0⁵,¹⁶]hexadeca-1,5(16),6,8,12-pentaen-14-yl]methyl acetate

C30H43N3O3 (493.3304)

2-[({1-[(2,7-dihydroxy-5-isopropyl-1,6-diazacyclododeca-1,3,6,9-tetraen-8-yl)-c-hydroxycarbonimidoyl]-2-methylpropyl}-c-hydroxycarbonimidoyl)amino]-3-methylbutanoic acid

C24H39N5O6 (493.29)

(3s,3ar,4s,6s,6ar,10s,12r,15as)-3-benzyl-1,6,12-trihydroxy-4,10,12-trimethyl-5-methylidene-3h,3ah,4h,6h,6ah,9h,10h,11h,15h-cycloundeca[d]isoindol-15-yl acetate

C30H39NO5 (493.2828)

2-{[(1-{[(3e,9z)-2,7-dihydroxy-5-isopropyl-1,6-diazacyclododeca-1,3,6,9-tetraen-8-yl]-c-hydroxycarbonimidoyl}-2-methylpropyl)-c-hydroxycarbonimidoyl]amino}-3-methylbutanoic acid

C24H39N5O6 (493.29)

(2s,3r,4r,5s,6s)-6-{[(1s,2s,3s,4r,6r)-4,6-diamino-3-{[(2r,3s,6r)-3-amino-6-[(methylamino)methyl]oxan-2-yl]oxy}-2-hydroxycyclohexyl]oxy}-2-(hydroxymethyl)-3-methyl-4-(methylamino)oxane-3,5-diol

C21H43N5O8 (493.3111)

6,10,19-trimethyl-24-oxa-4-azaheptacyclo[12.12.0.0²,¹¹.0⁴,⁹.0¹⁵,²⁵.0¹⁸,²³.0¹⁹,²⁵]hexacosane-10,12,13,14,22,23-hexol

C27H43NO7 (493.3039)

methyl (4z,8s,9e,11e)-2-hydroxy-4,8,12-trimethyl-15-[2-oxo-1-(2-phenylethyl)-5h-pyrrol-3-yl]pentadeca-4,9,11-trienoate

C31H43NO4 (493.3192)

(1s,2s,6s,9s,10s,11r,12s,13s,14s,15s,18s,19s,22s,23s,25r)-6,10,19-trimethyl-24-oxa-4-azaheptacyclo[12.12.0.0²,¹¹.0⁴,⁹.0¹⁵,²⁵.0¹⁸,²³.0¹⁹,²⁵]hexacosane-10,12,13,14,22,23-hexol

C27H43NO7 (493.3039)

(1r,2r,3z,5r,7s,9z,11r,12s,14r,15s,16r,17s)-17-benzyl-5,19-dihydroxy-5,7,14,15-tetramethyl-13-oxa-18-azatetracyclo[9.8.0.0¹,¹⁶.0¹²,¹⁴]nonadeca-3,9,18-trien-2-yl acetate

C30H39NO5 (493.2828)

11-ethyl-8-hydroxy-6,16,18-trimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl acetate

C27H43NO7 (493.3039)

(2s,5s,6r,7s,10s,14s)-3-hydroxy-5-(1h-indol-3-ylmethyl)-7,8,14,16-tetramethyl-4,21-diazatetracyclo[16.2.1.0²,⁶.0²,¹⁰]henicosa-1(20),3,8,11,15,18-hexaen-17-one

C32H35N3O2 (493.2729)

3-hydroxy-5-(1h-indol-3-ylmethyl)-7,8,14,16-tetramethyl-4,21-diazatetracyclo[16.2.1.0²,⁶.0²,¹⁰]henicosa-1(20),3,8,11,15,18-hexaen-17-one

C32H35N3O2 (493.2729)

(2s)-2-[(2s,5r,6s)-6-[(3e,5e)-6-[(1r,3as,4r,5s,7ar)-1-ethyl-4-(1h-pyrrole-2-carbonyl)-2,3,3a,4,5,7a-hexahydro-1h-inden-5-yl]hexa-3,5-dien-3-yl]-5-methyloxan-2-yl]propanoic acid

C31H43NO4 (493.3192)

(3s,3ar,4s,6s,6ar,10s,12r,15r,15ar)-3-benzyl-1,6,12-trihydroxy-4,10,12-trimethyl-5-methylidene-3h,3ah,4h,6h,6ah,9h,10h,11h,15h-cycloundeca[d]isoindol-15-yl acetate

C30H39NO5 (493.2828)

(1r,2r)-2-[(2s,4e,6z,8r,9s,11r,13s,15s,16s)-7-(aminomethyl)-8,16-dihydroxy-9,11,13,15-tetramethyl-18-oxo-1-oxacyclooctadeca-4,6-dien-2-yl]cyclopentane-1-carboxylic acid

C28H47NO6 (493.3403)

2-(6-{6-[1-ethyl-4-(1h-pyrrole-2-carbonyl)-2,3,3a,4,5,7a-hexahydro-1h-inden-5-yl]hexa-3,5-dien-3-yl}-5-methyloxan-2-yl)propanoic acid

C31H43NO4 (493.3192)

(2r,3r,6s,8r,12r,16s,20r,21s)-14-ethyl-4,6,19,21-tetramethoxy-16-(methoxymethyl)-9,11-dioxa-14-azaheptacyclo[10.7.2.1²,⁵.0¹,¹³.0³,⁸.0⁸,¹².0¹⁶,²⁰]docosane

C27H43NO7 (493.3039)

3-[(3s,6s,9s,17ar)-3-[(2s)-butan-2-yl]-1,4,7-trihydroxy-6-isopropyl-10-methylidene-13-oxo-3h,6h,9h,11h,12h,15h,16h,17h,17ah-pyrrolo[1,2-a]1,4,7,10,13-pentaazacyclopentadecan-9-yl]propanoic acid

C24H39N5O6 (493.29)

(2r)-2-[(5s,6r)-6-[(3e,5e)-6-[(1s,3ar,4s,5r,7as)-1-ethyl-4-(1h-pyrrole-2-carbonyl)-2,3,3a,4,5,7a-hexahydro-1h-inden-5-yl]hexa-3,5-dien-3-yl]-5-methyloxan-2-yl]propanoic acid

C31H43NO4 (493.3192)

(3s,3ar,4s,6as,10s,12r,15r,15as)-3-benzyl-1,12-dihydroxy-5-(hydroxymethyl)-4,10,12-trimethyl-3h,3ah,4h,6ah,9h,10h,11h,15h-cycloundeca[d]isoindol-15-yl acetate

C30H39NO5 (493.2828)

(1s,2s,6s,9s,10s,11r,12r,13s,15s,19s,22s,23s)-6,10,19-trimethyl-24-oxa-4-azaheptacyclo[12.12.0.0²,¹¹.0⁴,⁹.0¹⁵,²⁵.0¹⁸,²³.0¹⁹,²⁵]hexacosane-10,12,13,14,22,23-hexol

C27H43NO7 (493.3039)

(3r,6s,9e)-5,8,13-trihydroxy-14-(1-hydroxy-4-methyldecan-3-yl)-3-isopropyl-6-methyl-11-methylidene-1-oxa-4,7,12-triazacyclotetradeca-4,7,9,12-tetraen-2-one

C26H43N3O6 (493.3152)

(2r)-2-[(2r,5s,6r)-6-[(3e,5e)-6-[(1s,3as,4r,5r,7ar)-1-ethyl-4-(1h-pyrrole-2-carbonyl)-2,3,3a,4,5,7a-hexahydro-1h-inden-5-yl]hexa-3,5-dien-3-yl]-5-methyloxan-2-yl]propanoic acid

C31H43NO4 (493.3192)

(3r,6r,9e,14s)-5,8,13-trihydroxy-14-[(3r,4s)-1-hydroxy-4-methyldecan-3-yl]-3-isopropyl-6-methyl-11-methylidene-1-oxa-4,7,12-triazacyclotetradeca-4,7,9,12-tetraen-2-one

C26H43N3O6 (493.3152)

14-ethyl-4,6,19,21-tetramethoxy-16-(methoxymethyl)-9,11-dioxa-14-azaheptacyclo[10.7.2.1²,⁵.0¹,¹³.0³,⁸.0⁸,¹².0¹⁶,²⁰]docosane

C27H43NO7 (493.3039)